Cargando…

The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study

The Escherichia coli protein toxin cytotoxic necrotizing factor 1 (CNF1), which acts on the Rho GTPases that are key regulators of the actin cytoskeleton, is emerging as a potential therapeutic tool against certain neurological diseases characterized by cellular energy homeostasis impairment. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabbri, Alessia, Travaglione, Sara, Maroccia, Zaira, Guidotti, Marco, Pierri, Ciro Leonardo, Primiano, Guido, Servidei, Serenella, Loizzo, Stefano, Fiorentini, Carla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073533/ https://www.ncbi.nlm.nih.gov/pubmed/29933571 http://dx.doi.org/10.3390/ijms19071825

Ejemplares similares

The Bacterial Toxin CNF1 Protects Human Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine-Induced Cell Damage: The Hypothesis of CNF1-Promoted Autophagy as an Antioxidant Strategy
por: Travaglione, Sara, et al.
Publicado: (2020)

The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases
por: Travaglione, Sara, et al.
Publicado: (2014)

CNF1 Increases Brain Energy Level, Counteracts Neuroinflammatory Markers and Rescues Cognitive Deficits in a Murine Model of Alzheimer's Disease
por: Loizzo, Stefano, et al.
Publicado: (2013)

Correction: CNF1 Increases Brain Energy Level, Counteracts Neuroinflammatory Markers and Rescues Cognitive Deficits in a Murine Model of Alzheimer's Disease
por: Loizzo, Stefano, et al.
Publicado: (2013)

The bacterial protein CNF1 as a new strategy against Plasmodium falciparum cytoadherence
por: Messina, Valeria, et al.
Publicado: (2019)

Cell-to-Cell Propagation of the Bacterial Toxin CNF1 via Extracellular Vesicles: Potential Impact on the Therapeutic Use of the Toxin
por: Fabbri, Alessia, et al.
Publicado: (2015)

Effects of the Escherichia coli Bacterial Toxin Cytotoxic Necrotizing Factor 1 on Different Human and Animal Cells: A Systematic Review
por: Carlini, Francesca, et al.
Publicado: (2021)

CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J Mice
por: Travaglione, Sara, et al.
Publicado: (2015)

Cnf1 Variants Endowed with the Ability to Cross the Blood–Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma
por: Colarusso, Andrea, et al.
Publicado: (2020)

Effects of the Rho GTPase‐activating toxin CNF1 on fibroblasts derived from Rett syndrome patients: A pilot study
por: Cittadini, Camilla, et al.
Publicado: (2023)

Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1): Toxin Biology, in Vivo Applications and Therapeutic Potential
por: Fabbri, Alessia, et al.
Publicado: (2010)

The Rho-activating CNF1 toxin from pathogenic E. coli: A risk factor for human cancer development?
por: Travaglione, Sara, et al.
Publicado: (2008)

Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins?
por: Fiorentini, Carla, et al.
Publicado: (2020)

CNF1 Improves Astrocytic Ability to Support Neuronal Growth and Differentiation In vitro
por: Malchiodi-Albedi, Fiorella, et al.
Publicado: (2012)

The Cytotoxic Necrotizing Factor 1 from E. Coli: A Janus Toxin Playing with Cancer Regulators
por: Fabbri, Alessia, et al.
Publicado: (2013)

The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells
por: Gall-Mas, Laura, et al.
Publicado: (2018)

Sleep Disorders in Mitochondrial Diseases
por: Brunetti, Valerio, et al.
Publicado: (2021)

Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases
por: Cadoni, Gabriella, et al.
Publicado: (2023)

O035. Headaches in Mitochondrial Disorders
por: Vollono, Catello, et al.
Publicado: (2015)

The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model
por: Vannini, Eleonora, et al.
Publicado: (2014)

The bacterial toxin CNF1 as a tool to induce retinal degeneration reminiscent of retinitis pigmentosa
por: Guadagni, Viviana, et al.
Publicado: (2016)

Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation
por: Urbinati, Chiara, et al.
Publicado: (2021)

Spinal Cord Involvement in Adult Mitochondrial Diseases: A Cohort Study
por: Primiano, Guido, et al.
Publicado: (2021)

Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment
por: Pizzo, Federica, et al.
Publicado: (2022)

Corrigendum: The bacterial toxin CNF1 as a tool to induce retinal degeneration reminiscent of retinitis pigmentosa
por: Guadagni, Viviana, et al.
Publicado: (2016)

Vitamin D in Neurological Diseases
por: Plantone, Domenico, et al.
Publicado: (2022)

Novel TOP3A Variant Associated With Mitochondrial Disease: Expanding the Clinical Spectrum of Topoisomerase III Alpha–Related Diseases
por: Primiano, Guido, et al.
Publicado: (2022)

Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
por: Primiano, Guido, et al.
Publicado: (2020)

Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs
por: Tragni, Vincenzo, et al.
Publicado: (2022)

Fourier-Transform Infrared Spectroscopy of Skeletal Muscle Tissue: Expanding Biomarkers in Primary Mitochondrial Myopathies
por: Gervasoni, Jacopo, et al.
Publicado: (2020)

Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study
por: Primiano, Guido, et al.
Publicado: (2021)

CACNA1A-p.Thr501Met mutation associated with familial hemiplegic migraine: a family report
por: Romozzi, Marina, et al.
Publicado: (2021)

New Insights Regarding Hemin Inhibition of the Purified Rat Brain 2-Oxoglutarate Carrier and Relationships with Mitochondrial Dysfunction
por: Miniero, Daniela Valeria, et al.
Publicado: (2022)

Electro-cumulation CNF project
por: Grishin, V G
Publicado: (2000)

Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages
por: Vannini, Eleonora, et al.
Publicado: (2017)

SARS-CoV-2 infection in patients with primary mitochondrial diseases: Features and outcomes in Italy
por: Mancuso, Michelangelo, et al.
Publicado: (2021)

Cross-Activation of Two Nitrogenase Gene Clusters by CnfR1 or CnfR2 in the Cyanobacterium Anabaena variabilis
por: Pratte, Brenda S., et al.
Publicado: (2021)

A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy
por: Southwell, Nneka, et al.
Publicado: (2023)

Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients
por: Musumeci, Olimpia, et al.
Publicado: (2019)

(1,0)-Super Solutions of (k,s)-CNF Formula
por: Fu, Zufeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_40bjsak3hkgkduijr1rott7trg